| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | +0.29% | +0.98% | -0.69% | -0.69% | — |
| 14d | 2 | +100.00% | +1.56% | +1.02% | +0.54% | +0.54% | — |
| 30d | 2 | +50.00% | -4.28% | +0.99% | -5.27% | -5.27% | — |
| 60d | 2 | +50.00% | +0.94% | +3.24% | -2.30% | -2.30% | — |
| 90d | 2 | +100.00% | +6.25% | +3.56% | +2.68% | +2.68% | — |
| 180d | 2 | +50.00% | -4.90% | +3.29% | -8.19% | -8.19% | — |
| 1y | 2 | +100.00% | +111.06% | +15.53% | +95.53% | +95.53% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,050,000 | — | — | 1,050,000 | Mar 5, 2026 | Mar 6, 2026 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 750,000 | — | — | 750,000 | Mar 10, 2025 | Mar 12, 2025 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 15,000 | $0.59 | $8.8K | 25,500 | Nov 26, 2024 | Nov 26, 2024 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,500 | $0.89 | $9.3K | 10,500 | Aug 16, 2024 | Aug 19, 2024 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 650,000 | — | — | 650,000 | Mar 7, 2024 | Mar 8, 2024 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Mar 9, 2023 | Mar 10, 2023 ↗ | View → |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,000,000 | — | — | 1,000,000 | Nov 14, 2022 | Nov 16, 2022 ↗ | View → |